Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients

被引：0
|
作者：
Fumi Umeoka
Yoshiaki Iwasaki
Masayuki Matsumura
Akinobu Takaki
Haruhiko Kobashi
Masashi Tatsukawa
Hidenori Shiraha
Shin-ichi Fujioka
Kohsaku Sakaguchi
Yasushi Shiratori
机构：
[1] Okayama University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] Dentistry,Division of Gastroenterology
[3] and Pharmaceutical Sciences,undefined
[4] The Institute for Adult Disease,undefined
[5] Asahi Life Foundation,undefined
来源：
Journal of Gastroenterology | 2006年 / 41卷
关键词：
hepatitis B virus; lamivudine; fluorescent biprobe hybridization assay; mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：693 / 701
页数：8
相关论文
共 50 条
  • [31] Viral dynamics with frequent sampling during tenofovir therapy in patients with lamivudine-resistant hepatitis B virus mutants
    van der Eijk, AA
    Hansen, BE
    Niesters, HGM
    van der Ende, ME
    Schalm, SW
    de Man, RA
    JOURNAL OF HEPATOLOGY, 2004, 40 : 126 - 127
  • [32] In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir
    Lada, O
    Benhamou, Y
    Cahour, A
    Katlama, C
    Poynard, T
    Thibault, V
    ANTIVIRAL THERAPY, 2004, 9 (03) : 353 - 363
  • [33] Screening of new antivirals for lamivudine-resistant hepatitis B virus.
    Ono-Nita, SK
    Kato, N
    Shiratori, Y
    Yoshida, H
    Kato, J
    Schinazi, RF
    Omata, M
    HEPATOLOGY, 1999, 30 (04) : 346A - 346A
  • [34] Emergence and characterization of lamivudine-resistant hepatitis B virus variant.
    Naoumov, NV
    Chokshi, S
    Smith, HM
    Williams, R
    HEPATOLOGY, 1996, 24 (04) : 621 - 621
  • [35] Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus
    Kim, KM
    Choi, WB
    Lim, YS
    Lee, HC
    Chung, YH
    Lee, YS
    Suh, DJ
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (05) : 821 - 828
  • [36] Lamivudine-resistant hepatitis B virus in newly diagnosed HIV patients with chronic hepatitis B in Spain
    Trevino, A.
    Soriano, V.
    Rodriguez, C.
    Madejon, A.
    Barros, C.
    Parra, P.
    Tuma, P.
    del Romero, J.
    de Mendoza, C.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A65 - A65
  • [37] Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B
    Quarleri, J.
    Moretti, F.
    Bouzas, M. B.
    Laufer, N.
    Carrillo, M. Gomez
    Giuliano, S. Fernandez
    Perez, H.
    Cahn, P.
    Salomon, H.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 525 - 531
  • [38] Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy
    Xiao-Lin Deng
    Qing-Ling Li
    Jin-Jun Guo
    Virus Genes, 2013, 47 : 1 - 9
  • [39] Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication
    van Bömmel, F
    Wünsche, T
    Schürmann, D
    Berg, T
    HEPATOLOGY, 2002, 36 (02) : 507 - 508
  • [40] Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine
    Kumashiro, R
    Kuwahara, R
    Ide, T
    Koga, Y
    Arinaga, T
    Hisamochi, A
    Ogata, K
    Tanaka, K
    Sata, M
    INTERVIROLOGY, 2003, 46 (06) : 350 - 354
12345